A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1994
11/15/1994	US5364762 Major histocompatibility complex (MHC) molecules
11/15/1994	US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/15/1994	US5364622 Antisticking of organs
11/15/1994	US5364619 Oncoimmunins
11/15/1994	US5364350 Twin-chamber syringe filled with a charge of activity-sensitive human protein
11/15/1994	CA1333048C Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction
11/13/1994	CA2123261A1 Urethanes and ureas that induce cytokine production
11/12/1994	CA2123252A1 Polypeptide and dnas encoding it
11/12/1994	CA2123251A1 Polypeptide and dnas encoding it
11/12/1994	CA2123250A1 Polypeptide and dnas encoding it
11/12/1994	CA2123249A1 Polypeptide and dnas encoding it
11/12/1994	CA2122937A1 Human chondromodulin-i protein
11/12/1994	CA2102266A1 Stackable table, table assembly, and tray and table combination
11/11/1994	CA2123144A1 Stabilisation of pharmacologically active compounds in sustained release compositions
11/11/1994	CA2122814A1 Method for treating acquired immune deficiency syndrome
11/10/1994	WO1994025627A1 Methods of treating and detecting cancer using viruses
11/10/1994	WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	WO1994025625A1 Means for detecting familial colon cancer (fcc)
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025610A1 Compositions and methods for immunotherapy with the alpha-3 domain of a class i major histocompatibility molecule
11/10/1994	WO1994025608A1 Natural or recombinant dna binding proteins as carriers for gene transfer or gene therapy
11/10/1994	WO1994025604A2 Steroid 21-hydroxylase fragments and assays using the same
11/10/1994	WO1994025601A2 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	WO1994025585A1 Transgenic non-human animals capable of producing heterologous antibodies
11/10/1994	WO1994025582A1 Method of enhancing thrombolysis
11/10/1994	WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	WO1994025570A1 Method for screening for targets for anti-inflammatory or anti-allergic agents
11/10/1994	WO1994025565A1 HUMAN $i(SYK)
11/10/1994	WO1994025491A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	WO1994025485A1 Oxytocin antagonist
11/10/1994	WO1994025484A1 Biologically active peptides
11/10/1994	WO1994025483A1 Immunotherapeutic peptides derived from toxic shock syndrome toxin-1, antibodies thereto, their uses in pharmaceutical compositions and diagnosis
11/10/1994	WO1994025482A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
11/10/1994	WO1994025481A1 Method of separating glycosylated and non-glycosylated proteins
11/10/1994	WO1994025477A2 Novel peptide nucleic acids
11/10/1994	WO1994025476A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
11/10/1994	WO1994025435A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
11/10/1994	WO1994025073A1 Recombinant viruses and their use in gene therapy
11/10/1994	WO1994025068A1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/10/1994	WO1994025067A1 Antibodies to p-selectin and their uses
11/10/1994	WO1994025066A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/10/1994	WO1994025062A1 Oral pharmaceutical compositions containing renin inhibitors
11/10/1994	WO1994025061A1 Methods and compositions for treating diseases with carbohydrate modifying enzymes
11/10/1994	WO1994025059A1 Nutritional transfusion for peripheral vein administration
11/10/1994	WO1994025057A1 Kgf receptor-derived antagonists of kgf binding
11/10/1994	WO1994025056A2 Use of platelet-derived growth factor to improve collateral circulation
11/10/1994	WO1994025055A1 Erythropoietin analog compositions and methods
11/10/1994	WO1994025053A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	WO1994025052A1 Use of glutathione diesters
11/10/1994	WO1994025051A1 Thrombin inhibitors
11/10/1994	WO1994025050A1 Cyclohexapeptidyl propanolamine compounds
11/10/1994	WO1994025049A1 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
11/10/1994	WO1994025048A1 Cyclohexapeptidyl amine compounds
11/10/1994	WO1994025047A1 Inhibition of leukocyte adhesion
11/10/1994	WO1994025046A1 Method of combating acyclovir-resistant herpes simplex viral infections
11/10/1994	WO1994025045A1 Cyclohexapeptidyl aminoalkyl ethers
11/10/1994	WO1994025044A1 Calcitonin gene-related peptide-induced tolerance
11/10/1994	WO1994025043A1 Peptides and compounds that bind to elam-1
11/10/1994	WO1994025037A1 Anti-viral guanosine-rich oligonucleotides
11/10/1994	WO1994025005A1 Lyospheres comprising gonadotropin
11/10/1994	WO1994025000A1 Hookworm anticoagulant
11/10/1994	WO1994024870A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	WO1994024864A1 Methods of preventing viral replication
11/10/1994	WO1994023030A3 Methods and materials relating to the functional domains of dna binding proteins
11/10/1994	WO1994021800A3 Protein tyrosine phosphatase ptp-s31
11/10/1994	WO1994021781A3 Extracellular signal-regulated kinase, sequences, and methods of production and use
11/10/1994	WO1994021675A3 T cell epitopes of ryegrass pollen allergen
11/10/1994	WO1994017193A3 Chimeric l- and p-selectin by exchange of domains - uses thereof
11/10/1994	WO1994012649A3 Gene therapy for cystic fibrosis
11/10/1994	WO1994011518A3 Methods for converting a, ab, and b blood types to o blood type
11/10/1994	WO1994003075A3 Morphogen-enriched dietary composition
11/10/1994	DE4315437A1 Novel amino acid derivatives, process for their preparation and pharmaceutical compositions containing these compounds
11/10/1994	DE4315334A1 Serum albumin derivative and process for its preparation
11/10/1994	CA2662090A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2162056A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
11/10/1994	CA2161971A1 Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
11/10/1994	CA2161865A1 Peptides and compounds that bind to elam-1
11/10/1994	CA2161796A1 Hookworm anticoagulant
11/10/1994	CA2161772A1 Fibrin-targeted inhibitors of thrombin
11/10/1994	CA2161679A1 Recombinant virus and their use in genic therapy
11/10/1994	CA2161671A1 Methods of treating and detecting cancer using viruses
11/10/1994	CA2161669A1 Use of platelet-derived growth factor to improve collateral circulation
11/10/1994	CA2161656A1 Combined treatment of iron depletion and igg antibody
11/10/1994	CA2161651A1 Erythropoietin analog compositions and methods
11/10/1994	CA2161531A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	CA2161438A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
11/10/1994	CA2161243A1 Antiviral guanosine-rich oligonucleotides
11/10/1994	CA2161230A1 Novel peptide nucleic acids
11/10/1994	CA2161216A1 Amidino and guanidino substituted boronic acid inhibitors of tryspin-like enzymes
11/10/1994	CA2161150A1 Cyclohexapeptidyl propanolamine compounds
11/10/1994	CA2161149A1 Cyclohexapeptidyl aminoalkyl ethers
11/10/1994	CA2161114A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
11/10/1994	CA2161108A1 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
11/10/1994	CA2160909A1 Cell-targeted lytic pore-forming agents
11/10/1994	CA2160880A1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug
11/10/1994	CA2160716A1 Human syk
11/10/1994	CA2160703A1 Method of separating glycosylated and non-glycosylated proteins
11/10/1994	CA2159835A1 Cyclohexapeptidyl amine compounds
11/10/1994	CA2159834A1 Thrombin inhibitors

1 ... 2871 2872 2873 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 2891 ... 3163